| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.0095 | 1 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.0088 | 1 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |